Literature DB >> 17187941

Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.

Judith A Christian1, James L Bedford, Steve Webb, Michael Brada.   

Abstract

PURPOSE: Lungs are the major dose-limiting organ during radiotherapy (RT) for non-small-cell lung cancer owing to the development of pneumonitis. This study compared intensity-modulated RT (IMRT) with three-dimensional conformal RT (3D-CRT) in reducing the dose to the lungs.
METHODS: Ten patients with localized non-small-cell lung cancer underwent computed tomography (CT). The planning target volume (PTV) was defined and the organs at risk were outlined. An inverse-planning program, AutoPlan, was used to design the beam angle-optimized six-field noncoplanar 3D-CRT plans. Each 3D-CRT plan was compared with a series of five IMRT plans per patient. The IMRT plans were created using a commercial algorithm and consisted of a series of three, five, seven, and nine equidistant coplanar field arrangements and one six-field noncoplanar plan. The planning objectives were to minimize the lung dose while maintaining the dose to the PTV. The percentage of lung volume receiving >20 Gy (V20) and the percentage of the PTV covered by the 90% isodose (PTV90) were the primary endpoints. The PTV90/V20 ratio was used as the parameter accounting for both the reduction in lung volume treated and the PTV coverage.
RESULTS: All IMRT plans, except for the three-field coplanar plans, improved the PTV90/V20 ratio significantly compared with the optimized 3D-CRT plan. Nine coplanar IMRT beams were significantly better than five or seven coplanar IMRT beams, with an improved PTV90/V20 ratio.
CONCLUSION: The results of our study have shown that IMRT can reduce the dose to the lungs compared with 3D-CRT by improving the conformity of the plan.

Entities:  

Mesh:

Year:  2006        PMID: 17187941     DOI: 10.1016/j.ijrobp.2006.09.047

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

Review 1.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

2.  Dosimetry study of 18F-FMISO + PET/CT hypoxia imaging guidance on intensity-modulated radiation therapy for non-small cell lung cancer.

Authors:  H Li; D Xu; X Han; Q Ruan; X Zhang; Y Mi; M Dong; S Guo; Y Lin; B Wang; G Li
Journal:  Clin Transl Oncol       Date:  2018-04-05       Impact factor: 3.405

Review 3.  A review of intensity-modulated radiation therapy.

Authors:  Laurie E Gaspar; Meisong Ding
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

4.  Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.

Authors:  M Guckenberger; A Kavanagh; M Partridge
Journal:  Strahlenther Onkol       Date:  2012-08-31       Impact factor: 3.621

5.  Dosimetric evaluation of compensator intensity modulation-based stereotactic body radiotherapy for Stage I non-small-cell lung cancer.

Authors:  Y Tajima; H Nakayama; T Itonaga; S Shiraishi; M Okubo; R Mikami; S Sugahara; K Tokuuye
Journal:  Br J Radiol       Date:  2015-05-21       Impact factor: 3.039

Review 6.  Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Authors:  Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan
Journal:  Transl Lung Cancer Res       Date:  2017-04

7.  Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

Authors:  Sonal Sura; Vishal Gupta; Ellen Yorke; Andrew Jackson; Howard Amols; Kenneth E Rosenzweig
Journal:  Radiother Oncol       Date:  2008-03-17       Impact factor: 6.280

8.  Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.

Authors:  Minal S Kale; Grace Mhango; Marcelo Bonomi; Alex Federman; Keith Sigel; Kenneth E Rosenzweig; Juan P Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2016-09

Review 9.  Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy.

Authors:  Nikhil Yegya-Raman; Wei Zou; Ke Nie; Jyoti Malhotra; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

10.  Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial.

Authors:  Vasileios Askoxylakis; Julien Dinkel; Monika Eichinger; Bram Stieltjes; Gregor Sommer; Ludwig G Strauss; Antonia Dimitrakopoulou-Strauss; Annette Kopp-Schneider; Uwe Haberkorn; Peter E Huber; Marc Bischof; Jürgen Debus; Christian Thieke
Journal:  Radiat Oncol       Date:  2012-09-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.